Peptide Therapeutics Market was valued at USD 47.2 Million in 2023, and is expected to reach USD 93.0 Million in 2033, at a CAGR of 7.2% NEW Y ...

Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Tenaya Therapeutics Inc (NASDAQ:TNYA), with a price target of $18.00. This aligns with the strong overall analyst consensus, as ...

Companion Animal Health Management Market Pet owners are becoming increasingly aware of the importance of their pets' health and well-being ...

Transformative Scientific Breakthrough Pioneered by Spencer Trask & Co. Venture Osiris Therapeutics Kimberlin ... powerhouse at the forefront of regenerative medicine. "When we started with ...

Kroger Health, the healthcare division of The Kroger Co. and its Family of Pharmacies today announced a new agreement with Express Scripts, the pharmacy benefit services business of ...

It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures ... Inc; and Ratio Therapeutics LLC.

Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular ...

Jan. 28, 2025 /PRNewswire/ -- Beacon Therapeutics Holdings Limited ... U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to laru ...

Gene Holdings Inc. , a clinical-stage genetic medicines company whose non-viral lead investigational product detalimogene voraplasmid (also known as detalimogene, and previously EG-70) is in an ...